Formulation and Evaluation of Sustained Release Solid Dispersed Nifedipine Microcapsules
DOI:
https://doi.org/10.22270/ajdhs.v2i3.21Keywords:
Nifedipine, Poly vinyl pyrrolidone, Solid dispersion, Microcapsules, Emulsion solvent evaporation methodAbstract
Conventional drug delivery system for treating the angina and hypertension are not much effective as the drug do not reach the site of action in appropriate amounts. Thus potent and guarded therapy of this angina and hypertension disorder using specific drug delivery system is a challenging task to the pharmaceutical professionals. The study was aimed at increase the solubility of poorly soluble drug nifedipine and formulating it in sustained release dosage form. Solid dispersion of drug was prepared using Poly vinyl pyrrolidone (PVP) as inert hydrophilic carriers by solvent evaporation technique. A 17-fold increase in dissolution rate of nifedipine was observed with solid dispersion prepared with PVP (K30). Sustained release microcapsules of nifedipine were formulated using Eudragit RS 100 as a polymer, acetone as polymer solvent for Eudragit RS100, N-hexane as a non-solvent, liquid paraffin vehicle, with solid dispersion of nifedipine as core by emulsion solvent evaporation method and modified emulsion solvent evaporation method. Microcapsules from all the batches were found to discrete, spherical and free flowing and % entrapment efficiency was found to be in range of 96.01% to 97.87%. All the batches of microcapsules showed sustained release curve in pH 7.4 phosphate buffer up to 12hours with maximum release up to 97.22% after 12hrs was found to be in B2. SEM studies of the microcapsules showed the surface topography states that prepared microspheres were spherical in shape. Shiny and uniform covered surface with polymer.
Keywords: Nifedipine, Poly vinyl pyrrolidone, Solid dispersion, Microcapsules, Emulsion solvent evaporation method
References
Akinboboye O, Idris O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens. 2003; 17(6):381-7. https://doi.org/10.1038/sj.jhh.1001562
Okpechi IG, Rayner BL. Impact of recent landmark clinical trials on hypertension treatment. Clin Investig. 2011; 1(8):1141-54. https://doi.org/10.4155/cli.11.97
Barakat NS, Almurshedi AS. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation. J Pharm Pharmacol. 2011; 63(2):169-78. https://doi.org/10.1111/j.2042-7158.2010.01214.x
Sousa e Silva JP, Lobo JS, Bonifácio MJ, Machado R, Falcão A, Soares-da-Silva P. In-vivo evaluation of prolonged release bilayer tablets of anti-Parkinson drugs in Göttingen minipigs. J Pharm Pharmacol. 2011; 63(6):780-5. https://doi.org/10.1111/j.2042-7158.2011.01278.x
Derakhshandeh K, Soleymani M. Formulation and in vitro evaluation of nifedipine-controlled release tablet: Influence of combination of hydrophylic and hydrophobic matrix forms. Asian J Pharm. 2010; 4(4):185-193. https://doi.org/10.4103/0973-8398.76739
Lin SL, Menig J, Lachman L. Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water-insoluble drugs. J Pharm Sci. 1968; 57(12):2143-8. https://doi.org/10.1002/jps.2600571225
Kornblum SS, Hirschaorn JO. Dissolution of poorly water-soluble drugs. J Pharm Sci. 1970; 56:606-614. https://doi.org/10.1002/jps.2600590506
Parrot EL. Milling of pharmaceutical solids. J Pharma Sci. 1974; 63:813-820. https://doi.org/10.1002/jps.2600630603
Chiou WL, Riegelman S. Pharmaceutical application of solid dispersion systems. J Pharma Sci.1971; 60:1281-1302. https://doi.org/10.1002/jps.2600600902
Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs. J Pharm Sci. 1999; 88:1058-1066. https://doi.org/10.1021/js980403l
Sheen P, Khetarpal VK, Cariola CM, Rowlings CE. Formulation studies of poorly water soluble drug in solid dispersion to improve bioavaibility. Int J Pharm. 1995; 118:221-227. https://doi.org/10.1016/0378-5173(94)00366-D
Sahu V, Jadon AS, Jain N, Yadav R, Jain PK, Khare B, Jain A, Review on Microspheres as Drug Carriers for Controlled Drug Delivery. International Journal of Medical Sciences and Pharma Research, 2021; 7(2):1-9 https://doi.org/10.22270/ijmspr.v7i2.53
Mooter VG, Augustijns P, Blaton N, Kinget R. Physico-chemical characterization of solid dispersion of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm. 1998; 164:67-80. https://doi.org/10.1016/S0378-5173(97)00401-8
Tantishaiyakul V, Kaewnopparat N, Ingkataworn WS. Properties of solid dispersion of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm. 1996; 143:59-66. 11. https://doi.org/10.1016/S0378-5173(96)04687-X
Torrado S, Torrado JJ, Cadorniga R. Preparation dissolution and characterization of albendazole solid dispersion. Int J Pharm. 1996; 140:247-250. https://doi.org/10.1016/0378-5173(96)04586-3
Ho H, Su H, Tsai T, Sheu M. The preparation and characterization of solid dispersion on pellets using a fluidized bed system. Int J Pharm. 19996; 139:223- 229. https://doi.org/10.1016/0378-5173(96)04594-2
Perng CY, Kearney AS, Patel K, Palepu NR, Zuber G, et al. Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor. Int J Pharm. 1998; 176:31-38. https://doi.org/10.1016/S0378-5173(98)00296-8
Nair R, Gonen S, Hoag SW. Influence of polyethylene glycol and povidone and the polymorphic transformation and solubility of carbamazepine. Int J Pharm. 2002; 240:11-16. https://doi.org/10.1016/S0378-5173(02)00083-2
Mehta KA, Kislalioghu MS, Phuapradit W, Malick W, Shah NH. Multi unit controlled release systems of nifedipine and nifedipine: Pluronic F68 solid dispersions: Characterization of release mechanism. Drug Dev Ind Pharm. 2002; 28:275-286. https://doi.org/10.1081/DDC-120002843
Nagarajan K, Rao MG. Formulation and dissolution studies of solid dispersions of nifedipine. Indian Journal of Novel Drug Delivery 2010; 2:96-98.
More CG, Dabhade PS, Jain NP, Aher BO. Solubility and dissolution enhancement of gliclazide by solid dispersion technique. Int J Pharm Chem Anal. 2015; 2(2):51-8..
Vo CL, Park C, Lee BJ. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 2013; 85(3):799-813. https://doi.org/10.1016/j.ejpb.2013.09.007
Chowdary KPR, Ramesh S. Microencapsulation of solid dispersed Nifedipine-PVP system. Indian Drugs. 1995; 32 (10):477- 483.
Arias MJ, Gines JM, Moyano JR, Rabasco AM. Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols. Pharmaceutica Acta Helvetiae. 1996; 71(4):229-35. https://doi.org/10.1016/S0031-6865(96)00017-9
Nokhodchi A, Farid D. Microencapsulation of paracetamol: By various emulsion techniques using cellulose acetate phthalate. Pharm Tech North America. 2002; 26(6):54-60.
Wu PC, Huang YB, Chang JS, Tsai MJ, Tsai YH. Design and evaluation of sustained release microspheres of potassium chloride prepared by Eudragit®. Eur J Pharm Sci. 2003; 19(2-3):115-22. https://doi.org/10.1016/S0928-0987(03)00069-1
Gautam SP, Rai JP, Billshaiya U, Jain N, Vikram P, Jain DK. Formulation and evaluation of mouth dissolving tablet of loperamide. Int J Pharm Sci Res. 2013; 4(5):1782.
Patel AN, Rai JP, Jain DK, Banweer JI. Formulation, development and evaluation of cefaclor extended release matrix tablet. Int J Pharm Pharm Sci. 2012; 4(4):355-7.
Pandey SP, Khan MA, Dhote V, Dhote K, Jain DK. Formulation development of sustained release matrix tablet containing metformin hydrochloride and study of various factors affecting dissolution rate. Sch Acad J Pharm. 2019; 8(3):57-73.
Jain P, Nair S, Jain N, Jain DK, Jain S. Formulation and evaluation of solid dispersion of lomefloxacin hydrochloride. Int J Res Pharm Sci 2012; 3(4):604-608.
Published
How to Cite
Issue
Section
Citations
Copyright (c) 2022 Ayushi Patel, Rupesh Kumar Jain, Vivek Jain, Pushpendra Kumar Khangar

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.